AU5073400A - Sulfonamide compounds with pharmaceutical activity - Google Patents
Sulfonamide compounds with pharmaceutical activityInfo
- Publication number
- AU5073400A AU5073400A AU50734/00A AU5073400A AU5073400A AU 5073400 A AU5073400 A AU 5073400A AU 50734/00 A AU50734/00 A AU 50734/00A AU 5073400 A AU5073400 A AU 5073400A AU 5073400 A AU5073400 A AU 5073400A
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical activity
- sulfonamide compounds
- sulfonamide
- compounds
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- -1 Sulfonamide compounds Chemical class 0.000 title 1
- 229940124530 sulfonamide Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/48—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9912701 | 1999-06-01 | ||
| GBGB9912701.1A GB9912701D0 (en) | 1999-06-01 | 1999-06-01 | Novel compounds |
| PCT/EP2000/004893 WO2000073299A1 (en) | 1999-06-01 | 2000-05-25 | Sulfonamide compounds with pharmaceutical activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5073400A true AU5073400A (en) | 2000-12-18 |
Family
ID=10854529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU50734/00A Abandoned AU5073400A (en) | 1999-06-01 | 2000-05-25 | Sulfonamide compounds with pharmaceutical activity |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1181287A1 (en) |
| JP (1) | JP2003500488A (en) |
| AU (1) | AU5073400A (en) |
| GB (1) | GB9912701D0 (en) |
| WO (1) | WO2000073299A1 (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040267010A1 (en) * | 2001-02-02 | 2004-12-30 | Forbes Ian Thomson | Sulfonamide compounds, their preparation and use |
| AU2003252738A1 (en) * | 2002-08-09 | 2004-02-25 | Ajinomoto Co., Inc. | Remedy for intestinal diseases and visceral pain |
| JPWO2004069828A1 (en) * | 2003-02-04 | 2006-05-25 | 三菱ウェルファーマ株式会社 | Piperidine compounds and their pharmaceutical uses |
| GB0311201D0 (en) | 2003-05-15 | 2003-06-18 | Merck Sharp & Dohme | Therapeutic agents |
| MXPA06003150A (en) | 2003-09-17 | 2006-08-31 | Johnson & Johnson | Fused heterocyclic compounds. |
| DE602006008945D1 (en) | 2005-06-28 | 2009-10-15 | Sanofi Aventis | ISOCHINOLINE DERIVATIVES AS INHIBITORS OF RHO-KINASE |
| BRPI0613861B8 (en) | 2005-07-26 | 2021-05-25 | Sanofi Aventis | piperidinyl-substituted isoquinolone derivatives as rho-kinase inhibitors |
| US7598255B2 (en) | 2005-08-04 | 2009-10-06 | Janssen Pharmaceutica Nv | Pyrimidine compounds as serotonin receptor modulators |
| KR101517154B1 (en) | 2006-12-27 | 2015-04-30 | 사노피 | Substituted isoquinoline and isoquinolinone derivatives as inhibitors of Rho-kinase |
| MY151953A (en) | 2006-12-27 | 2014-07-31 | Sanofi Aventis | Cycloalkylamine substituted isoquinoline derivatives |
| RS51655B (en) | 2006-12-27 | 2011-10-31 | Sanofi-Aventis | Isoquinoline derivatives and isoquinolinone derivatives substituted by cycloalkylamine |
| CN101573353B (en) | 2006-12-27 | 2014-08-06 | 塞诺菲-安万特股份有限公司 | Substituted isoquinoline and isoquinolinone derivatives |
| JP5313919B2 (en) | 2006-12-27 | 2013-10-09 | サノフイ | Novel substituted isoquinoline and isoquinolinone derivatives |
| JP5405314B2 (en) | 2006-12-27 | 2014-02-05 | サノフイ | Cycloalkylamine substituted isoquinolone derivatives |
| HRP20131040T1 (en) | 2008-06-24 | 2013-12-06 | Sanofi | BI- AND POLYCYCLIC SUBSTITUTED ISOQINOLINE AND ISOQINOLINE DERIVATIVES AS RHO-KINASE INHIBITORS |
| KR101638326B1 (en) | 2008-06-24 | 2016-07-12 | 사노피 | Substituted isoquinolines and isoquinolinones as Rho kinase inhibitors |
| AU2009262516B8 (en) | 2008-06-24 | 2014-01-30 | Sanofi | 6-substituted isoquinolines and isoquinolinones |
| JP5641436B2 (en) * | 2011-03-28 | 2014-12-17 | 国立大学法人 鹿児島大学 | Anti-HIV drugs |
| MX2020012030A (en) * | 2018-05-11 | 2021-03-29 | Univ Temple | Novel functionalized lactams as modulators of the 5-hydroxytryptamine receptor 7 and their method of use. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0883613A1 (en) * | 1996-02-09 | 1998-12-16 | Smithkline Beecham Plc | Sulfonamide derivatives as 5ht7 receptor antagonists |
| GB9612884D0 (en) * | 1996-06-20 | 1996-08-21 | Smithkline Beecham Plc | Novel compounds |
| US6025367A (en) * | 1996-06-25 | 2000-02-15 | Smithkline Beecham Plc | Sulfonamide derivatives as 5HT7 receptor antagonists |
| WO1999009984A1 (en) * | 1997-08-28 | 1999-03-04 | Merck & Co., Inc. | Pyrrolidine and piperidine modulators of chemokine receptor activity |
-
1999
- 1999-06-01 GB GBGB9912701.1A patent/GB9912701D0/en not_active Ceased
-
2000
- 2000-05-25 EP EP00935141A patent/EP1181287A1/en not_active Withdrawn
- 2000-05-25 AU AU50734/00A patent/AU5073400A/en not_active Abandoned
- 2000-05-25 WO PCT/EP2000/004893 patent/WO2000073299A1/en not_active Ceased
- 2000-05-25 JP JP2000621365A patent/JP2003500488A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1181287A1 (en) | 2002-02-27 |
| GB9912701D0 (en) | 1999-08-04 |
| JP2003500488A (en) | 2003-01-07 |
| WO2000073299A1 (en) | 2000-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3569800A (en) | Pyrimidine compounds with pharmaceutical activity | |
| AU1071301A (en) | Pharmaceutical compounds | |
| AU5259100A (en) | Medicament | |
| AU2278601A (en) | Dual-mode processor | |
| HU0004123D0 (en) | New compounds with pharmaceutical activity | |
| AU1225000A (en) | Combined pharmaceutical estrogen-androgen-progestin | |
| AU2164101A (en) | Fungicidal combinations of active substances | |
| AU2270101A (en) | Pharmaceutical kit | |
| AU5073400A (en) | Sulfonamide compounds with pharmaceutical activity | |
| AU2919001A (en) | Syringe | |
| AU4328800A (en) | Pharmaceutical formulation | |
| AU5691800A (en) | Structure | |
| AU3838400A (en) | Processor | |
| AU1645700A (en) | Oenothein medicaments | |
| AU6748500A (en) | 9a-azalides with antibacterial activity | |
| AU5722900A (en) | Pharmaceutical compounds | |
| AU2543600A (en) | Fungicidal active substance combinations | |
| AU6036100A (en) | New pharmaceutically active compounds | |
| AU2201501A (en) | Structure | |
| AU1385801A (en) | Pharmaceutical formulations | |
| AU6480299A (en) | Pharmaceutical compounds | |
| AU3988100A (en) | Processor | |
| AU7450300A (en) | Sulfonamide derivatives | |
| AU3839900A (en) | Pharmaceutical formulation | |
| AU1752101A (en) | Medicament cartridge |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |